Change and Thinking of Criteria for Liver Transplantation Indications of Hepatocellular Carcinoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 姜楠 ,  杨扬

中山大学附属第三医院肝脏外科，中山大学器官移植研究所，广东省器官移植研究中心（广东广州 510630）;

Corresponding author：

杨扬, Email: yysysu@163.com

Keywords：

肝移植; 肝癌; 适应证

DOI：

10.7507/1007-9424.20140095

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 姜楠, 杨扬. Change and Thinking of Criteria for Liver Transplantation Indications of Hepatocellular Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(4): 389-391. doi: 10.7507/1007-9424.20140095 Copy

1.	Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699.
2.	Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J]. Hepatology, 2001, 33(6):1394-1403.
3.	Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:validation of the UCSF-expanded criteria based on preoperative imaging[J]. Am J Transplant, 2007, 7(11):2587-2596.
4.	Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?[J]. Cancer, 2000, 88(3):538-543.
5.	Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver transpl, 2002, 8(9):765-774.
6.	Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective, exploratory analysis[J]. Lancet Oncol, 2009, 10(1):35-43.
7.	Toso C, Trotter J, Wei A, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(8):1107-1115.
8.	Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma:Hangzhou experiences[J]. Transplantation, 2008, 85(12):1726-1732.
9.	Ferreira MV, Chaib E, Nascimento MU, et al. Liver transplantation and expanded Milan criteria:does it really work?[J]. Arq Gastroenterol, 2012, 49(3):189-194.
10.	Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis[J]. Hepatology, 2001, 33(5):1080-1086.
11.	Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma-Yes, of course![J]. J Hepatol, 2005, 43(4):569-573.
12.	Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded:a 22-year experience with 467 patients at UCLA[J]. Ann Surg, 2007, 246(3):502-509.
13.	Chen JW, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand[J]. HPB (Oxford), 2009, 11(1):81-89.
14.	Prasad KR, Young RS, Burra P, et al. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma:a review and consensus statement[J]. Liver Transpl, 2011, 17(S2):81-89.
15.	Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatoce-llular carcinoma liver transplantation:A single center analysis[J]. World J Gastroenterol, 2013, 19(36):6077-6083.
16.	Germani G, Gurusamy K, Garcovich M, et al. Which matters most:number of tumors, size of the largest tumor, or total tumor volume?[J]. Liver Transpl, 2011, 17(S2):58-66.
17.	Toso C, Asthana S, Bigam DL, et al. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database[J]. Hepatology, 2009, 49(3):832-838.
18.	Grat M, Kornasiewicz O, Hołówko W, et al. Evaluation of total tumor volume and pretransplantationα-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer[J]. Transplant Proc, 2013, 45(5):1899-1903.
19.	Yaprak O, Akyildiz M, Dayangac M, et al. AFP level and histo-logic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(3):256-261.
20.	Duvoux C, Roudot-Thoraval F, Decaens T, et al. Liver transplan-tation for hepatocellular carcinoma:a model includingα-fetopro-tein improves the performance of Milan criteria[J]. Gastroenterology, 2012, 143(4):986-994.
21.	Otto G, Schuchmann M, Hoppe-Lotichius M, et al. How to dec-ide about liver transplantation in patients with hepatocellular carc-inoma:size and number of lesions or response to TACE?[J]. J Hepatol, 2013, 59(2):279-284.

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699.
2. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J]. Hepatology, 2001, 33(6):1394-1403.
3. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:validation of the UCSF-expanded criteria based on preoperative imaging[J]. Am J Transplant, 2007, 7(11):2587-2596.
4. Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?[J]. Cancer, 2000, 88(3):538-543.
5. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver transpl, 2002, 8(9):765-774.
6. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective, exploratory analysis[J]. Lancet Oncol, 2009, 10(1):35-43.
7. Toso C, Trotter J, Wei A, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(8):1107-1115.
8. Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma:Hangzhou experiences[J]. Transplantation, 2008, 85(12):1726-1732.
9. Ferreira MV, Chaib E, Nascimento MU, et al. Liver transplantation and expanded Milan criteria:does it really work?[J]. Arq Gastroenterol, 2012, 49(3):189-194.
10. Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis[J]. Hepatology, 2001, 33(5):1080-1086.
11. Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma-Yes, of course![J]. J Hepatol, 2005, 43(4):569-573.
12. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded:a 22-year experience with 467 patients at UCLA[J]. Ann Surg, 2007, 246(3):502-509.
13. Chen JW, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand[J]. HPB (Oxford), 2009, 11(1):81-89.
14. Prasad KR, Young RS, Burra P, et al. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma:a review and consensus statement[J]. Liver Transpl, 2011, 17(S2):81-89.
15. Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatoce-llular carcinoma liver transplantation:A single center analysis[J]. World J Gastroenterol, 2013, 19(36):6077-6083.
16. Germani G, Gurusamy K, Garcovich M, et al. Which matters most:number of tumors, size of the largest tumor, or total tumor volume?[J]. Liver Transpl, 2011, 17(S2):58-66.
17. Toso C, Asthana S, Bigam DL, et al. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database[J]. Hepatology, 2009, 49(3):832-838.
18. Grat M, Kornasiewicz O, Hołówko W, et al. Evaluation of total tumor volume and pretransplantationα-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer[J]. Transplant Proc, 2013, 45(5):1899-1903.
19. Yaprak O, Akyildiz M, Dayangac M, et al. AFP level and histo-logic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(3):256-261.
20. Duvoux C, Roudot-Thoraval F, Decaens T, et al. Liver transplan-tation for hepatocellular carcinoma:a model includingα-fetopro-tein improves the performance of Milan criteria[J]. Gastroenterology, 2012, 143(4):986-994.
21. Otto G, Schuchmann M, Hoppe-Lotichius M, et al. How to dec-ide about liver transplantation in patients with hepatocellular carc-inoma:size and number of lesions or response to TACE?[J]. J Hepatol, 2013, 59(2):279-284.

Next Article
Indication of Liver Transplantation for Hepatocellular Carcinoma

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Change and Thinking of Criteria for Liver Transplantation Indications of Hepatocellular Carcinoma

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content